FAQ
Log In
Sunday 11th December 2016
News
 › 
 › 

NICE issue new guidance on psoriasis

10th July 2008

The National Institute for Health and Clinical Excellence (NICE) has issued new guidelines for the use of the anti-TNF drug adalimumab to treat adult patients with plaque psoriasis.

NICE say medical professionals could use the drug only in cases where the psoriasis is deemed to be severe and when other treatments such as ciclosporin or methotrexate have failed to improve the condition. It can also be prescribed where patients have experienced serious side effects from other treatments or those with medical reasons that prevent them from opting for the other options.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2016